Simple Summary Recently, radiogenomics has played a significant role and offered a new
understanding of cancer's biology and behavior in response to standard therapy. It also …

The heavy global burden and mortality of breast cancer emphasize the importance of early
diagnosis and treatment. Imaging detection is one of the main tools used in clinical practice …

The advent of immunotherapy, a groundbreaking advancement in cancer treatment, has
given rise to the prominence of the tumor microenvironment (TME) as a critical area of …

Currently, the research of multi‐omics, such as genomics, proteinomics, transcriptomics,
microbiome, metabolomics, pathomics, and radiomics, are hot spots. The relationship …

Breast cancer (BC) has yielded approximately 2.26 million new cases and has caused
nearly 685,000 deaths worldwide in the last two years, making it the most common …

Triple-negative breast cancer (TNBC) is a subset of breast cancer with an adverse prognosis
and significant tumor heterogeneity. Here, we extract quantitative radiomic features from …

The human microbiome encodes more than three million genes, outnumbering human
genes by more than 100 times, while microbial cells in the human microbiota outnumber …

Radiological imaging is an integral component of cancer care, including diagnosis, staging,
and treatment response monitoring. It contains rich information about tumor phenotypes that …

With the rapid development of new technologies, including artificial intelligence and genome
sequencing, radiogenomics has emerged as a state-of-the-art science in the field of …

Immunotherapies are leading to improved outcomes for many cancers, including those with
devastating prognoses. As therapies like immune checkpoint inhibitors (ICI) become a …